Search

everythinglearnresearchcommunity

for

Search:↓

Lower vitamin D levels are linked to higher CRP levels in people with a type of hair loss called alopecia areata.

Graham-Little Piccardi Lassueur Syndrome is a rare skin condition with specific hair loss and skin symptoms.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

JAK inhibitors show promise for treating skin conditions like eczema, hair loss, and psoriasis.

We need to learn more about 5α-reductases and neuroactive steroids to safely make drugs targeting these enzymes.

New treatments like nanotechnology show promise in improving skin cancer therapy.

Certain daily habits like stress, diet, and sleep can affect the severity of hair loss in alopecia areata.

Men and women get COVID-19 at similar rates, but men tend to get sicker and have a higher risk of dying, while women usually have stronger immune responses and vaccine reactions.

Nano-Pulse Stimulation™ Therapy is more effective and less damaging than cryoablation for treating melanoma tumors in mice.

Certain immune-related proteins are higher in people with alopecia and their healthy relatives, hinting at a genetic link.

Imiquimod can cause rare skin side effects, some irreversible, and long-term follow-up is important for users.

Using one's own blood platelets and fat can improve facial and hair appearance without surgery.

Two unusual cases showed that Lichen Planopilaris can look like other skin conditions and need early treatment to protect hair.

Enzymes called 5α-reductases have many body functions and need more research to safely use inhibitors.

Melanoma's complexity requires personalized treatments due to key genetic mutations and tumor-initiating cells.

Oxidative stress plays a significant role in alopecia areata, and new treatments may include JAK inhibitors and antioxidants.

Acyzol could help treat conditions caused by zinc deficiency.

Innate immunity genes in hair follicle stem cells might have new roles beyond traditional immune functions.

Medicinal herbs might treat hair loss by affecting genes and pathways related to lipid and glycerophospholipid metabolism.

Japanese patients with alopecia areata often have a higher BMI and consume more vitamin C, fruit, and retinol, which may affect their condition's development or severity.

Our microbiome may affect the development of the hair loss condition Alopecia Areata, but more research is needed to understand this relationship.

Biologic therapies can cause various adverse events, but allergy/immunology clinicians can manage them.

Further research is needed to understand how the microbiome affects hair loss in Alopecia Areata.

Non-scarring alopecia in females affects emotional well-being and requires accurate diagnosis and personalized treatment.

MJ04, a new compound, effectively promotes hair growth and is a potential topical treatment for hair loss.

Many popular skincare products claim to prevent aging but lack strong evidence to prove their effectiveness and safety.

People with common hair loss conditions may have a higher risk of heart disease and related health issues.

Experts recommend personalized treatment plans for best outcomes in managing Alopecia Areata.

The document encourages attending the 2023 Dermatology Nurses' Association Convention.